It turns out that American pharmaceutical company Moderna has submitted an application to the Ministry of Health, Labor and Welfare for approval required for the third dose of the new coronavirus vaccine.
The Ministry of Health, Labor and Welfare plans to start the third inoculation of the new coronavirus vaccine next month, and approved the use of Pfizer's vaccine for the third inoculation for the first time in Japan on the 11th.
According to the people concerned, Moderna also applied for approval necessary for the third vaccination through Takeda Pharmaceutical Company, which handles domestic distribution, on the 10th.
Along with the application, data on clinical trials conducted overseas for people aged 18 and over were submitted.
In the clinical trial, six months or more after the second vaccination, the amount of vaccine was halved from the second vaccination.
The Ministry of Health, Labor and Welfare has a policy of using the modelna vaccine for the third vaccination in the workplace by March next year, and after examining the efficacy and safety based on the submitted data, it will be approved by the end of the year. I am going to judge whether or not it is possible.